The clinical research landscape is shifting drastically due to an increase in the availability of electronic data allowing researchers to make assessments based on available real-world evidence (RWE) obtained from the analysis of real-world data (RWD). Global regulators are encouraging researchers/drug developers utilize the RWE for submissions. Many regulators are accepting the Real-world evidence (RWE) […]
Read More →Medical devices are regulated by the Medical Device Control Division (MDCO) from the office of Food and Drug Administration (FDA) in Thailand (also known as Thai FDA). Recently the Thai FDA has made many changes in regulatory requirements and approval process. Medical device market The medical devices industry is one of the high-potential sectors in […]
Read More →After the initiation of universal health care for their citizens in 2014 by the Indonesian government, the growth of the medical devices market improved and led to the rise in medical devices import. Medical device registration in Indonesia is a relatively fast and inexpensive process, particularly considering the size of the country. Highlights of Indonesia […]
Read More →The pharmaceutical market in Indonesia ranks the largest market in the ASEAN regions, with the market value expected to hit IDR 141.6 billion (USD 10.11 billion) by 2021. There is a steep increase in the number of drug registrations in Indonesia due to the huge market size and regulatory advantages over other countries. Key highlights […]
Read More →Globally many consider herbs and botanicals to be natural and therefore healthier and gentler than conventional drugs. Currently, 30% of prescription drugs are herbal and botanical drugs. Herbals and botanicals are used for the treatment and improvement of health and well-being. Many countries use herbal and botanical drugs traditionally for many years to generations. The […]
Read More →Lao People’s Democratic Republic (PDR) government is giving the highest priority to the healthcare sector, and this is creating a good opportunity for foreign country manufacturers like Indian and China to export low-cost high-quality generic drugs into Laos. Lao’s is a small country with a very small market for medical, health, and other pharmaceuticals. The […]
Read More →There is a growing demand for generic drugs in Malaysia. The government is the largest pharmaceutical buyer in Malaysia and is responsible for more than half of the purchasing value. The Indian, Chinese, and other similar drug manufacturers have begun playing a dominant role in the Malaysian pharmaceutical market. In Malaysia, the pharmaceutical manufacturing sector […]
Read More →Indonesia’s pharmaceutical market is the largest market in the Association of Southeast Nations (ASEAN). The current pharmaceutical market is worth IDR 84 trillion (USD 6 billion) and is expected to reach $10.11 billion by 2021. Some interesting facts about Indonesia The Indonesian Pharmacists Association reported that about 95 percent of raw material for medicine is […]
Read More →The Asia-Pacific region is emerging as a new destination for generic drugs. The Asia-pacific market is forecasted to grow from USD 75 billion in 2020 to USD 112 billion by 2025 at a CAGR of 8.34%. The growth of the generic drugs market is accelerated by many factors such as the aging population, increasing pharmaceutical […]
Read More →The demand for healthcare products and services has been growing in ASEAN countries. Governments start facing the same problem as in more developed countries and struggle to finance the growing healthcare expenses. There is a steep increase in chronic diseases along with infectious diseases. This is creating an opportunity for the generic drug manufacturers to […]
Read More →